EventsNewsKey PeopleResearchFundingLinksPublicationscontact

Under Construction - CFRC News updates coming October 2017

Kolls group and Constellation Pharmaceuticals Receive CF Foundation Research Grant

Constellation Pharmaceuticals, a biopharmaceutical company in the field of epigenetics, has been awarded a research grant in collaboration with the group of Dr. Jay Kolls to explore the potential use of BET bromodomain inhibitors for the control of inflammation in cystic fibrosis.
Dr. Kolls' laboratory has made fundamental contributions to the concept of inflammation as a key component of the pathophysiology of CF disease. The research supported by this grant will test the preclinical efficacy of novel anti-inflammatory compounds to reduce potential lung-damaging inflammation in people with cystic fibrosis.

MMR Seminars (2014-15) feature speakers of interest to CFRC
Conference Center, Rangos Res Ctr, CHP; Tuesdays at noon.
Seminar titles not yet available see MMR seminar announcements

Jay Kolls, MD Children's Hospital of Pittsburgh Sept. 2
David Brautigan, PhD University of Virginia; Phosphatase Regulation Sept. 23
Jason Gestwicki, PhD UCSF; Chaperones and Drug Development Oct. 14
Meir Aridor, PhD Cell Biology; University of Pittsburgh Nov. 4
Jeff Brodsky, PhD Biological Sciences; Univ. Pittsburgh Dec. 16
Joseph Zabner, MD University of Iowa; CF mucus and pH regulation Feb. 17

Biological Sciences Seminars (2014-15)
169 Crawford Hall, Mondays 4:15

Robert Piper, PhD University of Iowa; Lysosomal Protein Degradation Sept. 22
Jennifer Bomberger, PhDMMG; University of Pittsburgh Dec. 1
Phillip Sharp, PhD MIT; Nobel Laureat; All things related to RNA TBD

North American Cystic Fibrosis Conference (NACFC)

Salt Lake City, UT - October 16-20, 2013
Atlanta, GA - October 9-11, 2014

European Cystic Fibrosis Society (ECFS)

Gothenburg, Sweden - June 11-14, 2014
Brussels, Belgium - June 10-13, 2015
Basic Science Conference - TBD
Home | Events | News | Key People | Research | Funding | Links | Publications | Contact